Forecasting the Consequences of the Introduction of Mpox Virus into Russia
https://doi.org/10.21055/0370-1069-2026-2-108-112
Abstract
The cessation of vaccination after the eradication of smallpox led to a decrease in the level of herd immunity of the world’s population. Currently, the risk of national and international spread of Mpox is assessed as “high”. The introduction of MPXV clade 1b can be carried out by land or air transport by citizens of foreign countries or Russian tourists returning from a vacation abroad.
The aim of the study was to predict the consequences of the introduction of MPXV clade 1b into the territory of Russia.
Materials and methods. The data from published foreign and domestic scientific papers on the spread of Mpox, the values of average herd immunity and average basic reproductive number, as well as data characterizing the duration of post-vaccination immunity against orthopoxvirus infections were used.
Results and discussion. A forecast of the outbreak development as a result of the introduction of MPXV clade 1b into the territory of Russia in the absence of anti-epidemic measures has been made for three scenarios: a single imported case taking into account the size of the immune stratum of the population, a household outbreak, an outbreak in a closed community. The results of the forecast allow us to conclude that the introduction of MPXV clade 1b into the territory of Russia may lead to the emergence of a local or municipal emergency. In any of the considered scenarios, after the isolation of patients and those who have been in contact with them, the outbreak will cease.
About the Authors
V. B. KirillovRussian Federation
11, Oktyabrskaya St., Sergiev Possad-6, Moscow Region, 141306
S. L. Kirillova
Russian Federation
11, Oktyabrskaya St., Sergiev Possad-6, Moscow Region, 141306
S. V. Borisevich
Russian Federation
11, Oktyabrskaya St., Sergiev Possad-6, Moscow Region, 141306
References
1. Onishchenko G.G., Kirillov I.A., Borisevich S.V., Sizikova T.E., Krotkov V.T. [Analysis of aerobiological studies with orthopox- viruses by U.S. Department of Defense]. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology]. 2024; 101(3):399–411. DOI: 10.36233/0372-9311-522.
2. Haider N., Guitian J., Simons D., Asogun D., Ansumana R., Honeyborne I., Velavan T.P., Ntoumi F., Valdoleiros S.R., Petersen E., Kock R., Zumla A. Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs. Int. J. Infect. Dis. 2022; 122:107–11. DOI: 10.1016/j.ijid.2022.05.058.
3. Durski K.N., McCollum A.M., Nakazawa Y., Petersen B.W., Reynolds M.G., Briand S., Djingarey M.H., Olson V., Damon I.K., Khalakdina A. Emergence of monkeypox – West and Central Africa, 1970–2017. MMWR Morb. Mortal. Wkly Rep. 2018; 67(10):306–10. DOI: 10.15585/mmwr.mm6710a5.
4. WHO recommends new name for monkeypox disease. 28 November 2022. News release. Geneva, Switzerland. (Cited 01 Oct 2024). [Internet]. Available from: https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypoxdisease.
5. Ullah M., Li Y., Munib K., Zhang Z. Epidemiology, host range, and associated risk factors of monkeypox: an emerging global public health threat. Front. Microbiol. 2023; 14:1160984. DOI: 10.3389/fmicb.2023.1160984.
6. Bunge E.M., Hoet B., Chen L., Lienert F., Weidenthaler H., Baer L.R., Steffen R. The changing epidemiology of human monkeypox – a potential threat? A systematic review. PLoS Negl. Trop. Dis. 2022; 16(2):e0010141. DOI: 10.1371/journal.pntd.0010141.
7. Bernard S.M., Anderson S.A. Qualitative assessment of risk for monkeypox associated with domestic trade in certain animal species, United States. Emerg. Infect. Dis. 2006; 12(12):1827–33. DOI: 10.3201/eid1212.060454.
8. [WHO declares monkeypox a public health emergency of international concern]. (Cited 10 Jan 2025). [Internet]. Available from: https://news.un.org/ru/story/2022/07/1428232.
9. Tregubchak T.V., Bauer T.V., Maksyutov R.A., Gavrilova E.V. [Cases of orthopoxviral infections around the world over a period of 2008–2018]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2021; (3):33–9. DOI: 10.21055/0370-1069-2021-3-33-39.
10. World Health Organization. Multi-country outbreak of mpox, External situation report no. 44 – 23 December 2024. (Cited 28 Dec 2024). [Internet]. Available from: https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--externalsituation-report-44---23-december-2024.
11. Bbosa N., Nabirye S.E., Namagembe H.S., Kiiza R., Ssekagiri A., Munyagwa M., Bwambale A., Bagonza S., Bosa H.K., Downing R., Lutwama J., Kaleebu P., Ssemwanga D. Case reports of human monkeypox virus infections, Uganda, 2024. Emerg. Infect. Dis. 2025; 31(1):144–8. DOI: 10.3201/eid3101.241269.
12. WHO. WHO Director-General declares mpox outbreak a public health emergency of international concern. (Cited 10 Jan 2025). [Internet]. Available from: https://www.who.int/ru/news/item/14-08-2024-who-director-general-declares-mpox-outbreak-apublic-health-emergency-of-international-concern.
13. Srivastava S., Laxmi, Sharma K., Sridhar S.B., Talath S., Shareef J., Mehta R., Satapathy P., Sah R. Clade Ib: a new emerging threat in the Mpox outbreak. Front. Pharmacol. 2024; 15:1504154. DOI: 10.3389/fphar.2024.1504154.
14. SA records fourth Monkeypox case. (Cited 21 May 2024).. [Internet]. Available from: https://www.sanews.gov.za/south-africa/sa-records-fourth-monkeypox-case.
15. ECDC. Communicable disease threats report. Week 2, 4–10 January 2025. (Cited 20 Feb 2025). [Internet]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/communicabledisease-threats-report-week-2-2025.pdf.
16. [Temporary guidelines. Prevention, diagnosis and treatment of monkeypox]. Ministry of Health of the Russian Federation; 2022. 47 p. [Internet]. Available from: https://remedium.ru/upload/medialibrary/e1c/b1mf53tcvjf6kk1p73839htelh8znsiv/Vmr-ospaobezjan-2022.pdf.
17. Al-Raeei M. The study of human monkeypox disease in 2022 using the epidemic models: herd immunity and the basic reproduction number case. Ann. Med. Surg. 2023; 85(2):316–21. DOI: 10.1097/MS9.0000000000000229.
18. Grant R., Nguyen L.L., Breban R. Modelling human-to-human transmission of monkeypox. Bull. World. Health. Organ. 2020; 98(9):638–40. DOI: 10.2471/BLT.19.242347.
19. Bragazzi N.L., Iyaniwura S.A., Han Q., Woldegerima W.A., Kong J.D. Quantifying the basic reproduction number and underestimated fraction of Mpox cases worldwide at the onset of the outbreak. J. R. Soc. Interface. 2024; 21(216):20230637. DOI: 10.1098/rsif.2023.0637.
20. [Russian Statistical Yearbook]. 2024: Statistical book. Moscow: Rosstat; 2024. 630 p.
Review
For citations:
Kirillov V.B., Kirillova S.L., Borisevich S.V. Forecasting the Consequences of the Introduction of Mpox Virus into Russia. Problems of Particularly Dangerous Infections. 2026;(2):108-112. (In Russ.) https://doi.org/10.21055/0370-1069-2026-2-108-112
JATS XML




































